Conference 2024 Program

Scientific Session 1: Infectious Diseases

Time (EST)TopicSpeaker
07:00 - 07:15 AMWelcomeDr. Eleanor Fish, Dr. Payam Zarin
07:15 - 07:50 AMKeynote: Immune surveillance of the liverDr. Matteo Iannacone
Division of Immunology, Infectious Diseases and Transplantation, San Raffaele Scieic Institute, Italy
07:55 - 08:10 AMDissecting the far-reaching effects of intestinal inflammation on the upper gastrointestinal tractGustavo Monasterio
Karolinska Institute and University Hospital, Sweden
08:15 - 08:30 AMIdeying anti-pneumococcal molecules in the upper respiratory tract microbiomeNancy ElChaar
McMaster University, Canada
08:35 - 08:50 AMCytokine immune profiles among COVID 19 patients with different disease severities seeking treatment at Moi Teaching and Referral Hospital, KenyaJenniffer C. Sang
Kisii University, Kenya
08:55 - 09:10 AMPrimary nasal viral infection rewires tissue scale memory responseDr. Sam Kazer
Boston Children’s Hospital/Harvard University, U.S.A
09:15 - 09:30 AMSerine o-acetyltransferase protein in Leishmania donovani: Orchestrating thiol-based drug resistance and oxidative stress defenseAfreen Nawaz
ICMR-Rajendra Memorial Research Institute of Medical Sciences, India

Scientific Session 2: Chronic Diseases

Time (EST)TopicSpeaker
09:45 - 10:20 AMKeynote: Principles of resolving and non-resolving inflammationDr. Carla Rothlin
Yale University, School of Medicine, U.S.A.
10:25 - 10:40 AMTregs coach muscles to adapt to endurance exerciseDr. Kent Langston
Harvard Medical School, U.S.A
10:45 - 11:00 AMEvaluation of skeletal muscle mitochondrial respiratory capacity in response to a high-fat diet over timeDr. Fernanda Silva Carneiro
State University of Campinas, Brazil
11:05 - 11:20 AMInvestigation of the effect of Toll-like Receptor 4 and Fc-gamma Receptor III inhibition on macrophage activityDr. Rabia Bilge Özgül Özdemir
Manisa City Hospital, Turkey
11:25 - 11:40 AMCharacterizing interactions between dietary polyphenols and human gut microbiome on community-wide and strain-specific levelKexuan Huang
Columbia University, USA
11:45 - 12:00 PMBaicalin mitigates the neurochemical and the behavioral alterations in valproic acid-induced autismDr. Ahmed M. Kabel
ASRT, Egypt
12:05 - 12:20 PMModulatory effect of nicotinic acetylcholine receptors on the human memory T helper 1 and T helper 17 cellsFatemeh Gholizadeh
Concordia University, Canada
12:25 - 12:40 PMNon-canonical NF-κB signaling promotes intestinal inflammation by restraining the tolerogenic β-catenin-Raldh2 axis in dendritic cellsAlvina Deka, Naveen Kumar
NII, India
12:45 - 13:00 PMHotDoc: Leveraging youth voices in cancer control: To prevent takes and offers more than treatDr. Yakup Gözderesi
Turkish Ministry of Health Istanbul Bahcelievler State Hospital, Turkey
13:05 - 13:20 PMHotDoc: The Primary Care Dialogues PodcastEvangelia Savvidou
Aristotle University, Greece

Scientific Session 3: Cancer

Time (EST)TopicSpeaker
07:00 - 07:10 AMWelcomeDr. Eleanor Fish, Dr. Payam Zarin
07:15 - 07:50 AMKeynote: Transcriptional signatures reveal the immune response underlying progression and pathogenesis in tuberculosisDr. Anne O’Garra
Immunoregulation and Infection, The Francis Crick Institute, UK
07:55 - 08:10 AMMedullary sinus macrophages limit cancer therapy efficacy by an efferocytosis-induced IL-33/ST2 axis in the tumor-draining lymph nodeDr. Sara Lamorte
Princess Margaret Cancer Centre/University of Toronto, Canada
08:15 - 08:30 AMGlioblastoma mRNA vaccine: the possible modulation of tumor mRNA on the immune systemLetícia Andrade Savério
University of São Paulo, Brazil
08:35 - 08:50 AMOverexpression of miRNA-374 in Colorectal Cancer Patients and its Impact on Elevated TGFß1 LevelsDr. Noha G. Bader El Din, Dr. Sally Farouk
National Research Center, Egypt
08:55 - 09:10 AMAdding colchicine to doxorubicin for better anti-tumor efficacy and less toxicity in an in vivo cancer model; a step toward their use clinicallyRana M. El-Tabakh
Ain Shams University, Egypt
09:15 - 09:30 AMTumor killing by iNKT cellsCarolina de Amat Herbozo
University of Toronto, Canada
09:35 - 09:50 AMAdrenergic receptor signaling regulates the CD40-receptor mediated anti-tumor immunityDr. Akansha Singh
UT Southwestern Medical Centre, U.S.A

Scientific Session 4: IT, Bioinformatics, and Biotechnology

Time (EST)TopicSpeaker
10:00 - 10:35 AMKeynote: The TNFR Superfamily and Signal 4 for T cell activationDr. Tania Watts
Department of Immunology, University of Toronto, Canada
10:40 - 10:55 AMEngineering cytokine immunotherapies via cell surface targetingLuciano Santololani
MIT, U.S.A
11:00 - 11:15 AMSNAP-tag antibody conjugates targeting CD64 overexpressing cells in chronic diseasesEmmanuel Adebowale Fajemisin
University of Cape Town, South Africa
11:20 - 11:35 AMConcept of artificial intelligence oriented public health model in cancer careDr. Serhiy Hovornyan
Bukovinian State Medical University, Ukraine
11:40 - 11:55 AMTwo novel streptomyces strains for paracetamol-traces bioremediation with chemoinformatics, safety examination of biodegradation productsDonia H. Embarez
Ain Shams University, Egypt
12:00 - 12:15 PMComputer-aided drug design of some KRAS G12C inhibitors: Targeting the covalent and allosteric binding site for cancer therapyAbdeen Tunde Ogunlana
Ladoke Akintola University of Technology, Nigeria
12:20 - 12:35 PMCOVID-19 disease in children hospitalized at the Pediatric COVID19 Unit of P1, HMEAH – CHU Ibn Rochd – Casablanca : an epidemio-clinical studyHalima Kholaiq
Hassan II University, Morocco
12:40 - 12:55 PMHotDoc: Genotoxicity and mutagenicity of mercury in reproductive women and Yanomami children: Bibliographic reviewLeandra Nascimento Fonseca
Unicesumar, Brazil
13:00 - 13:15 PMHotDoc: Youth-led and youth-centered frontline against substance use: The story of LAMSADr. Zeina Moukarzel
LAMSA, Lebanon

2024 BSI Conferece Program Day 3